We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Category:Bio Products > Protein/Antigen/Polypeptide > Other Protein Product Name:HUALAN's Human Coagulation Factor VIII CAS No.:2021 Standard:ChP Price(USD):Negotiable Company:Hualan Biological Vaccine Inc.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: L/L
This product should be white, milky white loose powder, after redissolution, it should be colorless clear liquid, with a slight opalescence.
[Indications]
This product has a corrective effect on coagulation disorders that caused by the lack of human coagulation factor Ⅷ. It is mainly used in the prevention and treatment of hemorrhagic symptoms caused by hemophilia A and acquired coagulation factor Ⅷ deficiency and the surgical bleeding treatment of this kind of patients.
[Specification]
50IU/ bottle, each bottle contains the human coagulation factor 50IU, and the volume is 10ml after redissolution.
[Usage and dosage]
Usage: This product is intravenous infusion exclusively and it should be used under the strict supervision of clinicians. Before using, the product and its diluent should be pre-heated to 25~37℃. Then, the diluent is injected into the vial according to the labeled amount, gently shaking, so that the product is completely redissolved (be careful not to produce foam). Then intravenous infusion should use a blood transfusion set with a filter device, and the drip rate is usually about 60 drops per minute. Products should be used immediately after the redissolution, and used up within 1 hour, it shall not be placed.
Dosage: Dosage must refer to weight, presence of inhibitors, severity of bleeding and other factors.